BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1495750)

  • 1. Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.
    Finch RA; Chan PK
    Oncology; 1992; 49(3):223-6. PubMed ID: 1495750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
    Chan PK
    Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
    Yung BY; Bor AM; Chan PK
    Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
    Chan PK; Aldrich MB; Yung BY
    Cancer Res; 1987 Jul; 47(14):3798-801. PubMed ID: 2439199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cytotoxic drugs on translocation of nucleolar RNA helicase RH-II/Gu.
    Perlaky L; Valdez BC; Busch H
    Exp Cell Res; 1997 Sep; 235(2):413-20. PubMed ID: 9299166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
    Chan PK; Qi Y; Amley J; Koller CA
    Cancer Lett; 1996 Feb; 100(1-2):191-7. PubMed ID: 8620441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoprotein B23 translocation and modulation of actinomycin D and doxorubicin cytotoxicity by dipyridamole in HeLa cells.
    Bor AM; Chang FJ; Yung BY
    Int J Cancer; 1992 Oct; 52(4):658-63. PubMed ID: 1399149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis.
    Yung BY; Busch H; Chan PK
    Biochim Biophys Acta; 1985 Dec; 826(4):167-73. PubMed ID: 3907710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the reversibility of actinomycin D cytotoxicity in HeLa cells by verapamil.
    Yung BY; Chang FJ; Bor AM
    Cancer Lett; 1991 Dec; 60(3):221-7. PubMed ID: 1756512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation.
    Chan PK; Aldrich M; Busch H
    Exp Cell Res; 1985 Nov; 161(1):101-10. PubMed ID: 2414117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1).
    Yung BY; Busch RK; Busch H; Mauger AB; Chan PK
    Biochem Pharmacol; 1985 Nov; 34(22):4059-63. PubMed ID: 2415133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tumor cell sensitivity to mitomycin C by "B23 translocation" assay.
    Chan PK; Aldrich MB; Chakrabarty S
    Cancer Lett; 1988 Jun; 40(2):143-9. PubMed ID: 3133107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.
    Yung BY; Yang YH; Bor AM
    Int J Cancer; 1991 Jul; 48(5):779-84. PubMed ID: 2071236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-dependent effects of two consecutive, divided, low doses of actinomycin D on translocation of protein B23, inhibition of cell growth and RNA synthesis in HeLa cells.
    Yung BY; Chang FJ; Bor AM; Lee ES
    Int J Cancer; 1992 Sep; 52(2):317-22. PubMed ID: 1381705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of phosphoprotein B23 in proliferating and non-proliferating HeLa cells.
    Yung BY; Bor AM; Yang YH
    Int J Cancer; 1990 Aug; 46(2):272-5. PubMed ID: 2200756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D inhibition of monoclonal antibody binding to nucleolar phosphoprotein 37/5.2 (B23).
    Busch RK; Chan PK; Busch H
    Life Sci; 1984 Oct; 35(17):1777-85. PubMed ID: 6207410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants.
    Zatsepina OV; Todorov IT; Philipova RN; Krachmarov CP; Trendelenburg MF; Jordan EG
    Eur J Cell Biol; 1997 May; 73(1):58-70. PubMed ID: 9174672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
    Sweet P; Chan PK; Slater LM
    Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical localization of nucleophosmin and RH-II/Gu protein in nucleoli of HeLa cells after treatment with actinomycin D.
    Smetana K; Busch R; Chan PK; Smetana K; Busch H
    Acta Histochem; 2001 Jul; 103(3):325-33. PubMed ID: 11482378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The behavior of nucleolar proteins under the conditions of the reversible three-dimensional separation of the structural components of the nucleolus].
    Dudnik OA; Zatsepina OV
    Tsitologiia; 1995; 37(1-2):126-32. PubMed ID: 7571016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.